Literature DB >> 1973205

Clonal analysis of chronic myeloproliferative disorders using X-linked DNA polymorphisms.

B Anger1, J W Janssen, H Schrezenmeier, R Hehlmann, H Heimpel, C R Bartram.   

Abstract

Restriction fragment length polymorphisms of the X-chromosome genes phosphoglycerate kinase and hypoxanthine phosphoribosyl transferase were used to study clonality in peripheral blood leukocytes from 48 women with chronic myeloproliferative disorders (c-MPD). A total of 50% of patients were heterozygous for one or both of the polymorphic loci. These included 17 cases with polycythemia vera, four patients with essential thrombocythemia (ET), and three cases with idiopathic myelofibrosis (IMF). A clear-cut monoclonal X-inactivation pattern was observed in 17 of 24 cases including all IMF patients. Only one patient with PV exhibited a nonclonal composition of her leukocytes, while six cases demonstrated a predominantly clonal pattern in peripheral blood cells. Among the latter category reckoned three of four ET patients. Cell separation analyses were performed in one ET and three PV patients. In all four cases a monoclonal pattern of the granulocyte fraction could be established, while T lymphocytes of these patients were of nonclonal origin. These data suggest that the vast majority of c-MPDs arise from multipotent hematopoietic stem cells. Moreover, this type of clonal analysis might be of help in discriminating between primary MPD and reactive processes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973205

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  8 in total

Review 1.  Basic sciences of the myeloproliferative diseases: pathogenic mechanisms of ET and PV.

Authors:  Rosemary E Gale
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

Review 2.  Aging and Hematopoiesis.

Authors:  Emma M Groarke; Neal S Young
Journal:  Clin Geriatr Med       Date:  2019-05-09       Impact factor: 3.076

3.  Clonality in myeloproliferative disorders: analysis by means of the polymerase chain reaction.

Authors:  D G Gilliland; K L Blanchard; J Levy; S Perrin; H F Bunn
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

4.  Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly.

Authors:  Florian Zink; Simon N Stacey; Gudmundur L Norddahl; Michael L Frigge; Olafur T Magnusson; Ingileif Jonsdottir; Thorgeir E Thorgeirsson; Asgeir Sigurdsson; Sigurjon A Gudjonsson; Julius Gudmundsson; Jon G Jonasson; Laufey Tryggvadottir; Thorvaldur Jonsson; Agnar Helgason; Arnaldur Gylfason; Patrick Sulem; Thorunn Rafnar; Unnur Thorsteinsdottir; Daniel F Gudbjartsson; Gisli Masson; Augustine Kong; Kari Stefansson
Journal:  Blood       Date:  2017-05-08       Impact factor: 22.113

5.  Primary chronic myelofibrosis: clinical and prognostic evaluation in 336 Japanese patients.

Authors:  T Okamura; N Kinukawa; Y Niho; H Mizoguchi
Journal:  Int J Hematol       Date:  2001-02       Impact factor: 2.490

Review 6.  The therapy of myelofibrosis: targeting pathogenesis.

Authors:  Ruben A Mesa
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

7.  The majority of T lymphocytes are polyclonal during the chronic phase of chronic myelogenous leukemia.

Authors:  N Tsukamoto; M Karasawa; T Maehara; K Okamoto; H Sakai; T Naruse; K Morita; J Tsuchiya; M Omine
Journal:  Ann Hematol       Date:  1996-02       Impact factor: 3.673

8.  Evaluation of X-Chromosome Inactivation Patterns in Patients with Acute Myeloid Leukemia during Remission.

Authors:  Yousef Mortazavi; Saeid Kaviani; Fatemeh Mirzamohammadi; Kamran Alimoghaddam; Ali Akbar Pourfathollah; Oveis Salehi
Journal:  ISRN Hematol       Date:  2012-10-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.